Amazon: Analysts Expect $115.1 Billion In Q2 Revenue

Amazon.com Inc (NASDAQ: AMZN) will be reporting its second quarter financial results today after markets close. Analysts have a consensus $4,264.77 12-month price target on the company, via a total of 53 analysts, with 19 analysts having strong buy ratings. 33 analysts meanwhile have buy ratings and a single analyst has a hold rating. The street high comes from Susquehanna Financial with a $5,500 price target, and the lowest target sits at $3,775 from Loop Capital.

37 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 37 analysts is $115.14 billion; this number has been revised upwards from $102.65 billion at the start of the year. The highest revenue estimate is $120.76 billion, while the lowest is $11.34 billion.

The analyst consensus for net income for the second quarter is $6.55 billion, this is flat since the start of the year. The highest net income estimate is $7.82 billion, while the lowest is $5 billion.

Onto EBITDA estimates, there are currently 27 analysts who have second-quarter EBITDA estimates. The mean is currently $18.48 billion, with this number having been revised up from $16.38 billion at the start of the year. The street high estimate currently sits at $21.46 billion in EBITDA and the lowest is $16.26 billion.

Analysts estimate that quarterly earnings per share will come in at $12.30, with this number being slightly revised up from $10.83 at the start of the year. Street high is $15.18 and the lowest estimate is $9.77 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Drills 17.95 g/t Gold Over 22 Metres At Premier Mine

Denarius Metals Increases Bid For Emerita Resources To $0.45 Per Share

Related News

BMO Lowers Price Target On Equinox Gold Following Production Suspension At RDM Mine

Earlier this month Equinox Gold (TSX: EQX) revealed that they are temporarily suspending operations at...

Monday, May 30, 2022, 10:58:00 AM

Cresco Labs: Canaccord Bumps Price Target Up To $20.50

Wednesday, Canaccord came out with their updated valuations for the large three multi-state operators. With...

Sunday, January 17, 2021, 01:41:00 PM

Plug Power and the Perpetual Motion Machine

We wrote last week about hydrogen hopeful Plug Power (NASDAQ: PLUG)‘s aspirations of becoming a...

Sunday, January 31, 2021, 08:30:00 AM

Curaleaf: Canccord Slashes Price Target, Anticipates Headwinds For 2022

Earlier this month, Curaleaf Holdings, Inc. (CSE: CURA reported its fourth quarter and full year...

Monday, March 14, 2022, 09:27:00 AM

Tilray Sees Jefferies Lower Target Due To Canadian Cannabis Headwinds

Jefferies lowered their price target on Tilray Brands (TSX: TLRY), after updating their outlook, saying...

Sunday, April 10, 2022, 01:03:00 PM